HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN G (HIVIGG) TREATMENT OF MYASTHENIA GRAVIS: STUDY OF THE ANTI-IDIOTYPIC MECHANISMS OF ACTION AND PREPARATION OF SPECIFIC ANTI-ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY ANTI-IDIOTYPIC ANTIBODIES FROM COMMERCIALLY AVAILABLE
- 2 Years 1993/1995
- 29.438€ Total Award
Description unavailable
Scientific Publications
- 1993 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
THERAPIES FOR EXACERBATION OF MYASTHENIA-GRAVIS - THE MECHANISM OF ACTION OF INTRAVENOUS HIGH-DOSE IMMUNOGLOBULIN-G
- 1997 CLINICAL CHEMISTRY
Modified and improved anti-acetylcholine receptor (AChR) antibody assay: Comparison of analytical and clinical performance with conventional anti-AChR antibody assay
